Exit Strategies for Life Sciences Ventures

This 33-page Executive Report written for entrepreneurs and investors examines the ever-changing landscape of the life sciences world and how to determine potential exit strategies and carry them out successfully. From hitting the market at the appropriate time to making sure the IPO window doesn't shut too soon, there is an emphasis in these writings on timing. Key areas include how to gain the highest valuations, how life sciences exits differ from other industries (and the differences within them as well), and mistakes entrepreneurs often stumble upon.

Other topics include:

• the various phases of the exit
• how to find the best buyer
• the appropriate timeline and how to prepare for a buyer
• which exit to take based on type of company, stage of growth, and the market
• what characteristics the best exits tend to have
• how to assure management interests aren't overlooked
• how to focus on an exit without losing focus on the company

This Executive Report is written by:

• Howard D. Palefsky, General Partner, Montreux Equity Partners - The Best Strategies for Today's Market
• Karen Boezi, Co-Founder and Managing Director, Thomas, McNerney & Partners - Making Winning Choices and Avoiding Costly Mistakes
• James M. Garvey, Managing General Partner, SV Life Sciences Advisers Inc. - All Aspects of Strategic Exits
• Gilbert H. Kliman, M.D., General Partner, InterWest Partners - Minding the Market
• Teri F. Willey and Thomas W. Churchwell, Managing Partners, ARCH Development Partners LLC - Timelines, Due Diligence, and Key Questions
• T. Forcht Dagi, M.D., MPH., MBA, FACS, FCCM, Managing Partner, Cordova Ventures - Knowing Your Options
• Robert (Robin) Bellas, General Partner, Morgenthaler Ventures - Mapping the Best Strategy